EMI, the national leader in integrated solutions and services for industrial access, together with Morphosis Capital, announces the formation of an Advisory Board, composed of four top executives in the Romanian business environment – Gemma Webb, former CEO of British American Tobacco in Romania, Adela Jansen, partner at Druid, Cristian Covaciu, CEO of IPEC Alba and Florin Trandafirescu, former CEO of Unilever South-Central Europe.
“In the long run, our goal is for EMI to become the go-to one-stop shop for total industrial solutions and complex technical projects both in Romania and Europe. To achieve this, together with Morphosis Capital, we decided to bring next to us partners with business experience at the highest level. I thank the members of the Advisory Board for agreeing to be part of our story and our team, who is extremely involved at all levels. I am confident that together we will turn EMI into a major international player in the industrial access solutions industry,” stated Jerome France, founder and CEO of EMI.
Following the partnership with Morphosis Capital, EMI’s long-term goal is to become the go-to one-stop-shop for total industrial solutions and complex technical projects in Romania and Europe. The four members of the new Advisory Board will support EMI in carrying out its development plans, such as consolidating its position as a national leader in industrial access solutions, attracting new clients from new niches, and expanding into new markets through M&A transactions.
EMI has 21 years of experience on the Romanian market, specializing in industrial access solutions – doors, gates, shutters, curtains, fences, and other industrial enclosures. The company provides integrated solutions, from consulting, design, manufacturing, assembly, to maintenance and service, for global access solutions for the industrial, commercial, and logistics sectors. At its factory in Cateasca, EMI also develops unique technical solutions adapted to client needs.
Gemma Webb is an executive with over 40 years of experience in transforming businesses, with proven expertise in accelerated business growth. She has held leadership roles in companies from the FMCG or the tobacco industry in the United Kingdom, Belgium, Germany, and Romania throughout her professional career. Between 2012 and 2017, Gemma Webb was the CEO of British American Tobacco Romania and for the past two years, she has focused on providing advisory services to companies that want to improve specific business aspects, such as increasing sales, marketing activities, communication, or company profitability.
Adela Jansen has over 25 years of experience in top management, boards or advisory boards of various companies from multiple industries like financial services, FMCG, hospitality, telecom and business organizations, with expertise in business development, transformation processes, human resources, and governance. These include the French Chamber of Commerce in Romania, the Coalition for the Development of Romania, Envisia Boards of Elite, Holde Agri Invest, technology and financial services start-ups. She is a partner in Druid, an internationally expanding artificial intelligence company and associate professor at ASE.
Cristian Covaciu is a Romanian entrepreneur, co-founder, and CEO of IPEC Alba, the largest producer of household glassware in Europe, present on the Romanian market for over 30 years. In 2016, Cristian Covaciu was named EY Entrepreneur of the Year in Romania.
Florin Trandafirescu is a Romanian executive with extensive experience in FMCG. He has held various management positions within the Siemens group and the Unilever group for over 25 years, including ten years at the level of Managing Director, in several European countries.
“EMI is a solid and unique business in the industrial access solutions market, whose value has been built over 22 years of activity. The appointment of an Advisory Board is a natural step for a company that aims to accelerate the development of its product range and international presence. Gemma, Adela, Cristian, and Florin have extensive experience in their fields of activity, and I am convinced that their integration into the EMI team will bring added value and lead to the achievement of the company’s development objectives,” stated Simona Gemeneanu, Partner, Morphosis Capital.
In September 2021, Morphosis Capital announced the investment of 15 million euros together with the co-investors by acquiring the majority stake in EMI. This is the largest investment of the private equity fund, which also holds stakes in DocProcess, Medima Health, the Dr. Leahu Dental Clinics, Cronos Med, and Stay Fit Gym.
###
About EMI
EMI is the market leader in industrial access systems. Since its establishment in 2000, the company has specialized in integrated consulting, design, manufacturing, installation, maintenance and service solutions for industrial access solutions dedicated to industry, shopping centers and logistics centers. EMI has its own factory in Cateasca, near Pitesti, where it creates specific and bespoke solutions for the company’s clients. The factory is in the top of European manufacturers due to its high-performance production system, equipped with state-of-the-art equipment. EMI has developed intervention teams that cover the whole country and are available in a very short time, most of the interventions being carried out in a maximum of 24 hours.
About Morphosis Capital
Morphosis Capital is a private equity fund with 50 million euro committed capital. Established in December 2018 by four Romanian entrepreneurs, Simona Gemeneanu, Gabriela Dumitru, Dragos Petre, and Andrei Gemeneanu, the Fund aims to contribute to the development and transformation of the Romanian SMEs. The European Investment Fund (EIF), the leading financing platform for European SMEs, co-financed through the Regional Operational Programme, is the anchor investor in Morphosis Capital, while the founders themselves are the co-investors in the fund. Morphosis Capital invests between five to ten million euro in high growth Romanian companies from sectors such as FMCG, niche healthcare, technology, and B2B services, which have a strong potential for international expansion and an EBITDA of a minimum of half a million euro. Morphosis Capital portfolio includes DocProcess, Medima Health, Dr. Leahu Dental Clinics and EMI.
